iBio is a United States-based biotechnology company with a focus on streamlining the process of making a pharmaceutical product available on the market. It has developed platforms and has manufacturing facilities in Texas which can develop and product medical solutions such as vaccines, biotherapeutics, diagnostic products, and some medical devices.
The company's platform called FastPharming uses technology to expedite the development process for making medical solutions, such as the one necessary for COVID-19 due to the pandemic is has caused. iBio partnered with the Infectious Disease Research Institute (IDRI) to develop a vaccine where the company is set to provide process development and manufacturing services to IDRI, which is in charge of the pre-clinical development of the vaccine and clinical studies overview.
IBio Expands COVID-19 Vaccine Collaboration - Contract Pharma
iBio Joins the Alliance for Biosecurity
March 20, 2020
Documentaries, videos and podcasts
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.